01—Abstract
Summary
Summary of the 8-K filed September 10, 2026. Cited figures are marked; the original filing is the authoritative source.
Brown & Brown's 8-K (Item 7.01, furnished under Regulation FD) attaches a 2026 corporate overview presentation rather than new quarterly or annual results.
The deck is best read as an investor-relations update on the company's scale, profitability, and balance sheet after its acquisition of Accession (RSC Topco, Inc.). It cites about $5.9 billiona of 2025 revenue, roughly 23,000 teammates, and operations in 16 countries with over 700 locations. Its 2025 figures include $1.5 billion of operating cash flow (up 24% over 2024) and $1.1 billion of year-end cash.
Liquidity is described as $975 millionb of undrawn revolver capacity as of June 30, 2026, against a $1.25 billion facility. The deck's main financial message is consistent profitability and cash conversion, not top-line growth. Organic revenue growth was 2.8% in 2025 for both the Retail and Specialty Distribution segments, well below the 5-year averages it shows (6.5% for Retail and 11.5% for Specialty).
Adjusted EBITDAC margins were 30.0%c for Retail and 43.1% for Specialty in 2025. Growth is presented as largely acquisition-driven, with revenue growth of 24.8% for Retail and 19.5% for Specialty. The forward-looking risk factors explicitly flag that the Accession financing increased the company's indebtedness, which is the key balance-sheet item for investors to monitor.
The company targets net debt to EBITDAC of 0 to 2.5xd and has a covenant maximum of 3.5x. Shareholder-return claims are favorable over long periods but weak recently. The deck shows 10-year total shareholder return of 443% versus 365% for peers and 298% for the S&P 500, and it notes 32 consecutive years of dividend increases.
However, 1-year total shareholder return was -21%, against -4% for peers and +18% for the S&P 500. Investors should treat the presentation as promotional, since it uses non-GAAP measures (EBITDAC - Adjusted, organic revenue) and selects long-period comparisons. Its own reconciliations and risk language should be checked against the company's 10-K and 10-Q filings.
02—Key points
Key Highlights
- 2025 total revenue of approximately $5.9 billion, with about 23,000 teammates as of December 31, 2025, across 16 countries and more than 700 locations.
- Organic revenue growth was only 2.8% in 2025 for both Retail and Specialty Distribution, far below their 5-year averages of 6.5% and 11.5%, respectively.
- Adjusted EBITDAC margins remained high: 30.0% for Retail and 43.1% for Specialty Distribution in 2025.
- Operating cash flow was $1.5 billion in 2025, up 24% year over year, with $1.1 billion of cash on the balance sheet at December 31, 2025.
- Liquidity was $975 million of available revolver capacity as of June 30, 2026, out of a $1.25 billion facility, with an additional $1 billion expansion feature. The deck notes the Accession financing increased indebtedness.
- Shareholder returns were strong over 10 years (443% versus 365% for peers and 298% for the S&P 500) but weak over one year (-21%, versus -4% for peers and +18% for the S&P 500).
- The 2025 diluted EPS calculation was reduced by $0.17 due to a $54 million favorable mark-to-market of escrow liability and the inclusion of 4.4 million escrowed shares, a non-cash item that complicates comparisons.
03—Questions
Frequently Asked Questions
Does this 8-K report new financial results or guidance?
No. The filing furnishes a 2026 company overview presentation under Item 7.01 (Regulation FD) and Exhibit 99.1. It contains no new quarterly results or formal guidance, and the information is not deemed filed for Section 18 purposes. Investors should rely on the company's 10-K and 10-Q filings for audited and reviewed financials.
How much debt did the Accession acquisition add, and how levered is the company?
The filing does not give the exact new debt amount. It states that financing the Accession transaction increased the company's indebtedness and refers to debt outstanding as of 12/31/2025 in its leverage slides. The company targets a net debt to EBITDAC ratio of 0 to 2.5x and a total debt to EBITDAC ratio of 0 to 3.0x, with a covenant maximum net debt to EBITDAC of 3.5x. The exact current ratios are in the referenced reconciliation pages, which the excerpt does not fully show.
Why is organic growth so low compared with the company's historical levels?
The deck reports 2025 organic revenue growth of 2.8% in both segments, compared with 5-year averages of 6.5% for Retail and 11.5% for Specialty Distribution. The filing does not explain the slowdown in detail. Its risk factors cite items such as changes in commission revenue, carrier relationships, economic conditions, and reduced insurer capacity, which may be relevant. Investors should look for management commentary in the earnings materials.
Are the shareholder return figures in the deck reliable indicators of performance?
They are useful context but selective. The 10-year return of 443% is strong against peers and the S&P 500, but the 1-year return of -21% lags peers and the index. The deck is a promotional investor presentation, and its comparisons depend on the period chosen. Investors should weigh recent underperformance as heavily as the long-term record.
How should investors interpret the non-GAAP measures used in the presentation?
The deck relies on non-GAAP measures such as Organic Revenue, EBITDAC - Adjusted, Diluted EPS - Adjusted, and Free Cash Flow. These exclude items like acquisition and integration costs, amortization, changes in acquisition earn-out payables, and mark-to-market effects on escrowed shares. The company says these measures reflect operating performance and are used in incentive compensation. Investors should compare them with the GAAP reconciliations in the filing and in the periodic reports, and consider the 2025 escrow mark-to-market effect that reduced diluted EPS by $0.17.
04—Continue